122 related articles for article (PubMed ID: 16235346)
1. Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma.
Humber C; Tierney J; Symonds P; Collingwood M; Kirwan J; Williams C; Green J
Cochrane Database Syst Rev; 2005 Oct; (4):CD003915. PubMed ID: 16235346
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma.
Humber C; Tierney J; Symonds P; Collingwood M; Kirwan J; Williams C; Green J
Cochrane Database Syst Rev; 2005 Jul; (3):CD003915. PubMed ID: 16034916
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma.
Vale CL; Tierney J; Bull SJ; Symonds PR
Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD003915. PubMed ID: 22895938
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy for advanced, recurrent or metastatic endometrial cancer: a systematic review of Cochrane collaboration.
Humber CE; Tierney JF; Symonds RP; Collingwood M; Kirwan J; Williams C; Green JA
Ann Oncol; 2007 Mar; 18(3):409-20. PubMed ID: 17150999
[TBL] [Abstract][Full Text] [Related]
5. Procarbazine, lomustine and vincristine for recurrent high-grade glioma.
Parasramka S; Talari G; Rosenfeld M; Guo J; Villano JL
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD011773. PubMed ID: 28744879
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy for metastatic and recurrent cervical cancer.
Scatchard K; Forrest JL; Flubacher M; Cornes P; Williams C
Cochrane Database Syst Rev; 2012 Oct; 10(10):CD006469. PubMed ID: 23076924
[TBL] [Abstract][Full Text] [Related]
7. Hormonal therapy in advanced or recurrent endometrial cancer.
Kokka F; Brockbank E; Oram D; Gallagher C; Bryant A
Cochrane Database Syst Rev; 2010 Dec; 2010(12):CD007926. PubMed ID: 21154390
[TBL] [Abstract][Full Text] [Related]
8. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G
Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy alone versus chemotherapy plus radiotherapy for adults with early stage Hodgkin lymphoma.
Blank O; von Tresckow B; Monsef I; Specht L; Engert A; Skoetz N
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD007110. PubMed ID: 28447341
[TBL] [Abstract][Full Text] [Related]
10. Antiangiogenic therapy for high-grade glioma.
Khasraw M; Ameratunga MS; Grant R; Wheeler H; Pavlakis N
Cochrane Database Syst Rev; 2014 Sep; (9):CD008218. PubMed ID: 25242542
[TBL] [Abstract][Full Text] [Related]
11. High-dose chemotherapy followed by autologous stem cell transplantation for patients with relapsed/refractory Hodgkin lymphoma.
Rancea M; Monsef I; von Tresckow B; Engert A; Skoetz N
Cochrane Database Syst Rev; 2013 Jun; (6):CD009411. PubMed ID: 23784872
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant chemotherapy for endometrial cancer after hysterectomy.
Johnson N; Bryant A; Miles T; Hogberg T; Cornes P
Cochrane Database Syst Rev; 2011 Oct; 2011(10):CD003175. PubMed ID: 21975736
[TBL] [Abstract][Full Text] [Related]
13. High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults.
Schaaf M; Reiser M; Borchmann P; Engert A; Skoetz N
Cochrane Database Syst Rev; 2012 Jan; 1():CD007678. PubMed ID: 22258971
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.
Winter-Roach BA; Kitchener HC; Dickinson HO
Cochrane Database Syst Rev; 2009 Jan; (1):CD004706. PubMed ID: 19160239
[TBL] [Abstract][Full Text] [Related]
15. Comparison of first-line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma.
Skoetz N; Will A; Monsef I; Brillant C; Engert A; von Tresckow B
Cochrane Database Syst Rev; 2017 May; 5(5):CD007941. PubMed ID: 28541603
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant radiotherapy for stage I endometrial cancer.
Kong A; Johnson N; Kitchener HC; Lawrie TA
Cochrane Database Syst Rev; 2012 Mar; (3):CD003916. PubMed ID: 22419290
[TBL] [Abstract][Full Text] [Related]
17. Vascular-endothelial-growth-factor (VEGF) targeting therapies for endocrine refractory or resistant metastatic breast cancer.
Wagner AD; Thomssen C; Haerting J; Unverzagt S
Cochrane Database Syst Rev; 2012 Jul; (7):CD008941. PubMed ID: 22786517
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.
Winter-Roach BA; Kitchener HC; Dickinson HO
Cochrane Database Syst Rev; 2009 Jul; (3):CD004706. PubMed ID: 19588360
[TBL] [Abstract][Full Text] [Related]
19. Laparoscopy versus laparotomy for the management of early stage endometrial cancer.
Galaal K; Bryant A; Fisher AD; Al-Khaduri M; Kew F; Lopes AD
Cochrane Database Syst Rev; 2012 Sep; (9):CD006655. PubMed ID: 22972096
[TBL] [Abstract][Full Text] [Related]
20. Interval debulking surgery for advanced epithelial ovarian cancer.
Tangjitgamol S; Manusirivithaya S; Laopaiboon M; Lumbiganon P; Bryant A
Cochrane Database Syst Rev; 2010 Oct; (10):CD006014. PubMed ID: 20927744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
